Latest / The OBservations Podcast
AAPLOG’s Urgent Call for FDA Action on Chemical Abortion Pill Safety
In this episode of Caring for Both, a Curbside Consult Series by the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG), Jordan Butler sits down with Dr. Christina Francis, CEO of AAPLOG, to discuss a critical letter recently sent to the FDA and HHS. The letter urges immediate review of mifepristone—the first drug in the two-pill regimen commonly used for chemical abortions—amid growing concerns about safety and oversight.
Dr. Francis explains why AAPLOG is sounding the alarm now, what the data really show about complication rates, and how the dismantling of safeguards…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.